Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03130699 · ClinicalTrials.gov registry record · NA
Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes
A NA study of Diabetes Mellitus, Type 2, sponsored by Scripps Whittier Diabetes Institute.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 2
- Study locations
NCT03130699: Completed NA study of Diabetes Mellitus, Type 2, sponsored by Scripps Whittier Diabetes Institute.
NCT03130699 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Scripps Whittier Diabetes Institute. The registered enrollment target is 310 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03130699, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Scripps Whittier Diabetes Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that is tailored to individuals' needs and behavioral progress, in improving diabetes clinical control, adherence, and patient-provider communication in Hispanics - an at-risk, understudied population that experiences disparities in diabetes prevalence and outcomes. These striking disparities in the growing and aging US Hispanic population have taxed the US healthcare system, while significantly reducing quantity and quality of life for millions of individuals. By offering an innovative, scalable, and sustainable approach that seamlessly integrates several mHealth technologies into existing primary care team processes to improve the health of Hispanics (and eventually, other at-risk, underserved groups), DD-Me has strong potential to significantly impact public health.
Primary Outcome
Glycosylated Hemoglobin (HbA1c) six months after enrollment
Conditions Studied
Interventions
- BEHAVIORAL Dulce Digital
- BEHAVIORAL Dulce Digital-Me (Automated Delivery)
- BEHAVIORAL Dulce Digital-Me (Medical Assistant)
Study Locations (2)
California
- Scripps Mercy Chula Vista - Chula Vista
- Scripps Whittier Diabetes Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2017-10-31 |
| Est. Completion | 2021-08-14 |
| Phase | NA |
What the finished NCT03130699 record still lists
NCT03130699 is an interventional study that assigns participants to a tested intervention. The registered 310 participants enrollment target is mid-sized for trials with a published cap, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Dulce Digital is the first listed.
NCT03130699 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03130699 about?
NCT03130699 is a clinical study titled "Dulce Digital-Me: An Adaptive mHealth Intervention for Underserved Hispanics With Diabetes". This study will compare Dulce Digital (i.e., the investigators' proven-effective combination of "one-size-fits-all" educational text messages and nurse monitoring of patient-transmitted blood glucose values) and Dulce Digital-Me (DD-Me), an adaptive/dynamic mHealth (mobile health) intervention that ...
What is the current status of trial NCT03130699?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2017-10-31. Estimated completion is 2021-08-14.
What conditions does trial NCT03130699 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT03130699?
The interventions under investigation include: Dulce Digital (BEHAVIORAL), Dulce Digital-Me (Automated Delivery) (BEHAVIORAL), Dulce Digital-Me (Medical Assistant) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03130699?
This trial is sponsored by Scripps Whittier Diabetes Institute, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03130699 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03130699's enrollment target sits among peer trials
310 119th of 348 higher than 229 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
- NCT04878094 · 310 participants · Phase 3
A Study of Intra-operative Imaging in Women With Ovarian Cancer
- NCT05459233 · 310 participants · NA
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI